Defiance Autism Impact ETF

ASD

Valor de mercado US$ 1,34 mi

Matthew Bielski, founder and CEO of Defiance ETFs, recently joined Scarlet Fu and Eric Balchunas on Bloomberg's ETF IQ to discuss the Defiance Autism Impact ETF (ASD) and the personal family experience that helped inspire its development. Key Takeaways Personal experience inspired ASD.

As autism diagnoses rise, and research, regulation, and public awareness reshape the landscape, a broader neurodiversity care ecosystem is taking shape.

The autism care economy is expanding across healthcare, technology, education, and behavioral services. As a result, investors are beginning to look at the companies serving it through a broader investment lens.

ETFs allow investors a plethora of ways to express themselves while also pursuing performance. With each passing year, new ETFs arrive to help investors meet their personal and financial goals.

The arrival of June usually signals a seasonal slowdown for many people, but our ETF industry clearly missed the memo. Instead of heading to the beach or stopping to watch the World Cup, the ETF ecosystem had a wave of milestones, structural changing-of-the-guards, and high-profile index provider consolidation.

June has seen many ETF launches, from pure-play AI memory chip thematics to an autism impact fund that donates returns to nonprofits. With a record breaking 214 launches, the ETF landscape continues to expand into new markets.

The ETF ecosystem is always changing and growing. Thanks to the ETF's flexibility, transparency, and tradability, it can help investors achieve plenty of bespoke goals.

SAN FRANCISCO and BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced topline results from IRIS (ML-004-002), a Phase 2 study of ML-004 in autism spectrum disorder (ASD). The study randomized 161 participants (102 adolescents, 59 adults), with prespecified analyses planned by age group and baseline irritability severity.

The Defiance Autism Impact ETF (ASD) launched June 1 as the first fund built entirely around companies tied to autism care. Behind it is a personal story from inside the firm itself.

The first-ever autism ETF and the continued rise of quantum computing were both in the spotlight on this week's ETF Prime. Host Nate Geraci welcomed Sylvia Jablonski, chief investment officer of Defiance ETFs, to discuss the firm's latest launch and one of the market's top-performing funds.